Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Chlorhexidine hydrochloride, Hydrocortisone, Nystatin may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
FOR Nystaform HC Cream is a light yellow cream for application to the skin. It is used to treat skin infections caused by either fungi and/or bacteria, such as ringworm, athlete's foot and infected nappy rash. Corticosteroid creams, ointments and other topical preparations come in four different potencies or strengths. These are known as mild, moderately potent, potent or very potent. Healthcare professionals will usually refer to topical corticosteroid potency rather than strength. A potent or strong corticosteroid has a much stronger effect than a mild corticosteroid when using the same amount. The percentage of active ingredient that is sometimes included on product packaging does not indicate potency. Hydrocortisone is classed as a mild corticosteroid. Your healthcare professional will prescribe or advise a steroid of the appropriate potency for your condition.
E NYSTAFORM HC CREAM Do not use Nystaform HC Cream of this medicine (listed in section 6).
Warnings and precautions Talk to your doctor or pharmacist before using Nystaform HC Cream.
rash or asthma. If you notice these symptoms, stop using Nystaform HC Cream and contact your doctor as soon as possible (see under section 4). Take special care with Nystaform HC Cream external use only and should not be used near your eyes, mouth or be swallowed.
contact your doctor. hydrocortisone (steroid) may be absorbed into your bloodstream. cause the hydrocortisone (steroid) to be absorbed into your bloodstream. If there is a worsening of your condition during use consult your prescriber – you may be experiencing an allergic reaction, have an infection or your condition requires a different treatment. If you experience a recurrence of your condition shortly after stopping treatment, within 2 weeks, do not restart using the cream/ointment without consulting your prescriber unless your prescriber has previously advised you to so. If your condition has resolved and on recurrence the redness extends beyond the initial treatment area and you experience a burning sensation, please seek medical advice before restarting treatment. Children
Other medicines and Nystaform HC Cream Pregnancy, breast-feeding and fertility Do not use Nystaform HC Cream if you are pregnant or breast-feeding, think you may be pregnant
Important information about some of the ingredients of Nystaform HC Cream Nystaform HC Cream contains cetostearyl alcohol Nystaform HC Cream contains the ingredient cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis) in some patients. Nystaform HC Cream contains benzyl alcohol This medicine contains 10 mg benzyl alcohol in each gram of cream. Benzyl alcohol may cause allergic reactions and mild local irritation.
NYSTAFORM HC CREAM if you are not sure. For application to the skin only. Continue treatment for a maximum of seven days. If you forget to use Nystaform HC Cream
stop using Nystaform HC Cream and get immediate medical help: Swelling of the face, lips, tongue or throat; a red itchy skin rash; wheezing or difficulty breathing; feeling faint and dizzy; a strange metallic taste in the mouth; collapse. You
stop using it and talk to your doctor or pharmacist. treatment may need to be used.
Steroid withdrawal reaction: If used over prolonged periods a withdrawal reaction, which might appear to be different from the previous condition, may occur in some patients during treatment or within days to weeks after stopping treatment with some or all of the following features: redness of the skin which can extend beyond the initial area treated, a burning or stinging sensation, intense itching, peeling of the skin, oozing open sores. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
NYSTAFORM HC CREAM Keep this medicine out of the sight and reach of children. C.
What Nystaform HC Cream contains
What Nystaform HC Cream looks like and contents of the pack Nystaform HC Cream is a light yellow cream which comes in aluminium tubes of 15g and 30g.
Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Typharm Ltd, Unit 1, 39 Mahoney Green, Rackheath, Norwich, NR13 6JY.
Manufacturer This leaflet was last revised in January 2024.
1/NHC/05/2401/882.v7
Nystaform HC Cream comes as cream. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Nystaform HC Cream is chlorhexidine hydrochloride, hydrocortisone, nystatin.
This leaflet reproduces the patient information leaflet approved for Nystaform HC Cream, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Nystaform HC cream is indicated for the treatment of infected dermatoses where fungal (particularly monilial) and/or bacterial infections are present.
Posology
Adults and Children:
Apply to infected areas 2-3 times daily.
Treatment should be for a maximum period of 7 days.
Method of adminstration
For topical application only.
Tuberculous lesions of the skin. Known hypersensitivity to the active substances, especially in those with a history of possible chlorhexidine-related allergic reactions (see sections 4.4 and 4.8), or to any of the excipients listed in section 6.1.
For external use only. Avoid contact with eyes. If sensitivity occurs, or if new infection appears, discontinue use and institute alternative therapy.
Cetostearyl alcohol may cause local skin reactions (e.g. contact dermatitis).
This medicine contains 10 mg benzyl alcohol in each gram of cream. Benzyl alcohol may cause allergic reactions and mild local irritation.
Long term use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdrawal syndrome). A severe form of rebound flare can develop which takes the form of a dermatitis with intense redness, stinging and burning that can spread beyond the initial treatment area. It is more likely to occur when delicate skin sites such as the face and flexures are treated. Should there be a reoccurrence of the condition within days to weeks after successful treatment a withdrawal reaction should be suspected. Reapplication should be with caution and specialist advise is recommended in these cases or other treatment options should be considered.
The label will state mild steroid.
Paediatric population
In infants, long-term continuous topical steriod therapy should be avoided. Adrenal suppression can occur even without occlusion. As with other topical corticosteroids, systemic absorption may occur when extensive areas are treated, particularly under occlusion.
Nystaform HC Cream contains chlorhexidine. Chlorhexidine is known to induce hypersensitivity, including generalised allergic reactions and anaphylactic shock. The prevalence of chlorhexidine hypersensitivity is not known, but available literature suggests this is likely to be very rare. Nystaform HC Cream should not be administered to anyone with a potential history of an allergic reaction to a chlorhexidine-containing compound (see sections 4.3 and 4.8).
None stated.
Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate and intra-uterine growth retardation. The relevance of this finding to humans has not been established. However, topical steroids should not be used extensively in the first trimester of pregnancy and nystatin only with caution. The use of Nystaform HC Cream requires that the anticipated benefits outweigh the possible risks.
None stated.
Skin Disorders and Subcutaneous Tissue Disorders
Frequency not known (cannot be estimated from available data):Allergic skin reactions such as dermatitis, pruritus, erythema, eczema, rash, urticaria, skin irritation, and blisters. Withdrawal reactions - redness of the skin which may extend to areas beyond the initial affected area, burning or stinging sensation, itch, skin peeling, oozing pustules. (see section 4.4)
Immune Disorders
Frequency not known: Hypersensitivity including anaphylactic shock (see sections 4.3 and 4.4).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Nystatin is poorly absorbed from the gastro-intestinal tract. In the event of accidental oral ingestion, routine measures such as gastric lavage should be performed as soon as possible after ingestion.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Not the same combination. This medicine contains Chlorhexidine hydrochloride, Hydrocortisone, Nystatin. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Chlorhexidine hydrochloride, Hydrocortisone, Nystatin. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Nystaform HC Cream. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.